Milind Deshpande - 15 Sep 2022 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Director
Signature
/s/ Tamara Joseph, Attorney-in-Fact for Milind Deshpande
Issuer symbol
SPRO
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
4
Filing time
19 Sep 2022, 17:44:40 UTC
Previous filing
18 Aug 2021
Next filing
10 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Award $0 +15,000 +91% $0.000000 31,454 15 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on September 15, 2023, subject to the Reporting Person's continued service through the applicable vesting date.